C07D 311/66
With carbon atoms having three bonds to hetero atoms with at the
Official title: with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
C07D311/66 (With carbon atoms having three bonds to hetero atoms with at the) appears on 125 US grants and 73 published applications in this corpus.
Search patents in C07D- Granted patents
- 125
- Published applications
- 73
- Assignees
- 73
- Inventors
- 345
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 5 | 0 |
| 1989 | 3 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 1 | 0 |
| 1994 | 9 | 0 |
| 1995 | 6 | 0 |
| 1996 | 10 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 2 | 0 |
| 2000 | 3 | 0 |
| 2001 | 0 | 0 |
| 2002 | 5 | 6 |
| 2003 | 3 | 2 |
| 2004 | 3 | 8 |
| 2005 | 1 | 2 |
| 2006 | 3 | 1 |
| 2007 | 3 | 3 |
| 2008 | 0 | 6 |
| 2009 | 3 | 2 |
| 2010 | 3 | 3 |
| 2011 | 2 | 5 |
| 2012 | 3 | 2 |
| 2013 | 2 | 1 |
| 2014 | 3 | 2 |
| 2015 | 2 | 3 |
| 2016 | 3 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 3 |
| 2019 | 1 | 2 |
| 2020 | 1 | 1 |
| 2021 | 3 | 6 |
| 2022 | 1 | 3 |
| 2023 | 2 | 3 |
| 2024 | 1 | 6 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Synthesis of small molecules inspired by phomoxanthone A9 Jun 2026US 12,649,725 B2Worcester Polytechnic Institute
- Optically resolved Trolox intermediate and method for producing same30 Dec 2025US 12,509,434 B2PTC Therapeutics, Inc.
- Resist composition, method of forming resist pattern, compound, and acid diffusion-controlling agent16 Jan 2024US 11,874,601 B2Tokyo Ohka Kogyo.Co., Ltd.
- 4-(p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases12 Dec 2023US 11,840,497 B2PTC Therapeutics, Inc.
- Compounds as mPGES-1 inhibitors13 Jun 2023US 11,672,787 B2Khondrion IP B.V.
- Modulators of the integrated stress pathway8 May 2025US 2025/0145594 A1AbbVie Inc.
- Solid state forms of abexinostat and process for preparation thereof22 Aug 2024US 2024/0279195 A1Teva Pharmaceuticals International GmbH
- Substituted sulfonamide-chroman compounds, and pharmaceutical compositions, and methods of use thereof6 Jun 2024US 2024/0182436 A1Sumitomo Pharma America, Inc.
- Modulators of eukaryotic initiation factor 22 May 2024US 2024/0140919 A1Denali Therapeutics Inc.
- Chemicals and use of hypohalites in mechanism-based selective dual radical organic synthesis25 Apr 2024US 2024/0132430 A1Walker Cancer Research Institute, Inc.
Most cited
By later US patents
- Substituted aminomethyltetralins and their heterocyclic analogues81US 5,137,901 ABayer Aktiengesellschaft · 1992
- Hypoglycaemically and hypolipidaemically active derivatives of phenyl-alkane-carboxylic acids75US 4,238,506 ABoehringer Mannheim GmbH · 1980
- Substituted pyridines50US 6,031,105 APfizer Inc. · 2000
- Leukotriene B.sub.4 antagonists45US 5,324,743 AEli Lilly and Company · 1994
- Tocopherols, tocotrienols, other chroman and side chain derivatives and uses therof41US 6,417,223 B1Research Development Foundation · 2002